This month, we are shining a light on the multiple myeloma community to help raise awareness of this cancer that affects plasma cells in the bone marrow. Our patient community has shared that broader awareness can help demystify the disease and lead to enhanced knowledge and understanding. #MultipleMyeloma
"A useful tool for #patient organizations. To help them formalise #patientengagement partnerships with companies & make it everyone's responsibility," #live feedback from a #patientengagement champion @ #PEOF. Wonderful co-creation! Explore the tool ➡️https://t.co/TEa806VGtz
Want to find out what patients PREFER?
Join us on 28 April 2022 🗓️ to launch the @IMI_PREFER recommendations on why, when and how to assess and use #PatientPreferences in medical product decision-making! #PatientEngagement
👉 https://t.co/Uo2kilEs77
The 5 asks:
- Improve education and awareness about skin cancer
- Protect citizens from excessive exposure to UV radiation
- Recognise skin cancer as an occupational disease
- Improve registration of cases
- Improve early detection of skin cancer in high-risk groups
#MelSM
💡This #WorldCancerDay we must address the often-forgotten challenges of #BreastCancer.
📌#TBCT calls on policymakers to ensure returning to work is as smooth as possible for patients.
👉 Read more from #TBCT#CloseTheCareGap
https://t.co/CdNR7bVOIj
I’m excited to join the #EPFCongress2021 as a Moderator where we’ll explore the #digitaltransformation of healthcare.
Join me online with @eupatientsforum from the 📆 26-29 October to highlight the added value of patient partnerships.
Register ➡ https://t.co/sHeZrZJGKb
I just gave a virtual keynote to the leadership of @Novartis.
They asked me to focus on the near future of oncology, the impact of advanced technologies on patients' lives and how a pharma company can prepare for all this.
#themedicalfuturist#future#speaker#keynote#novartis
The 15th #EuropeanPatientsRightsDay is taking place this 18 April 2021.
But what is the @imi_eupearl project doing to support patients rights and meaningful involvement?
Read our blog post to learn more: https://t.co/Dr5LFeMBHF @eupatientsforum @IMI_JU
Healthcare systems are under unprecedented pressure but we need to take action to actively address cancer care. To claim the need for action we are sending a Joint letter on #COVID19andCancer. You can still sign it!
Read it, endorse it & spread the word➡️ https://t.co/j9sLW7ASVo
🔴Now live: join us for the launch of the @cancereu joint letter on #COVID19andCancer ➡ https://t.co/4MMhgAJbry
On #WorldHealthDay, we want all governments to make a difference by saying: “I am committed, & I will invest in prevention, early diagnosis and treatment of cancer.”
Ivana Cattaneo (@EFPIA): 'There is a need for agility in research & development. I call for institutions to get together, cancer patients cannot wait, it is the time to stop fragmentation' #COVID19andCancer#WorldHealthDay#WorldHealthDay2021
Patients and patient reps with an interest in #HTA can get a free pass to attend the 2021 HTAi annual meeting. They only need to apply by 16 April. Check below for more info @eupatientsforum#pcigpass#patientsinvolved
Isabel Rubio from ESSO will be speaking at #TBCT’s webinar to raise awareness around the increased challenges #BreastCancer patients face due to #Covid19. Make sure to tune in #ChallengingBreastCancer https://t.co/W14JxDFVRO
How can we avoid major disruptions in #Cancer services in the event of a global pandemic? Tomorrow our president Fatima Cardoso will discuss main learnings from the #Covid19 crisis & ongoing challenges that must be addressed. Join us, register now! https://t.co/thhPExvKvg
28 February is Rare Disease Day. Stand up for all the people and their families living with rare diseases for equitable access to health and social care #RareDiseaseDay